Jefferies is serving as Financial Advisor on the pending $10.9 billion strategic acquisition and sale to AbbVie, marking one of the largest healthcare and biopharma transactions in the sector.
| Sector | Healthcare / Life Sciences |
| Transaction Value | $10,900,000,000 |
| Jefferies Role | Financial Advisor |
| Status | Pending Regulatory Closing |
Transaction Overview & Strategic Impact
- Expands commercial biopharma pipeline access and clinical scale under AbbVie’s global therapeutics portfolio.
- Reinforces Jefferies’ premier positioning in landmark global healthcare and life sciences M&A advisory.
